Portal de Periódicos da CAPES

Managing puerperium in patients with systemic autoimmune diseases: an update

2022; Taylor & Francis; Volume: 18; Issue: 4 Linguagem: Inglês

10.1080/1744666x.2022.2050216

1744-8409

Cecilia Nalli, Lucia Manfredi, Micaela Fredi, Francesca Crisafulli, Stefania Bertocchi, J. Kh. Khizroeva, В. О. Бицадзе, А. D. Makatsariya, Sonia Zatti, Laura Andréoli, Franco Franceschini, Anǵela Tincani,

Maternal Mental Health During Pregnancy and Postpartum

Puerperium is a critical period for patients affected by autoimmune rheumatic diseases for the risk of disease's flares and difficulties in treating lactating mothers. We want to summarize the literature data about psychological and pharmacological management of these patients and possible risk factors of disease's flares.We made a narrative review on recent studies about puerperium in rheumatic autoimmune diseases patients.The physicians involved in management of patients during puerperium and in the follow-up of babies need to agree on maternal treatment because they need to reassure mothers about the safety of the prescribed medications. Furthermore, women with rheumatic diseases could present some musculoskeletal limitations and psychological problems, such as postpartum depression, which can lead to a sense of inadequacy to the mother's task. Families and physicians should be aware of these possible complications and support the new mothers providing correct counseling and practical help.